Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
960 participants
INTERVENTIONAL
2019-11-26
2027-10-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auditory Deficits in Congenital Amusia (AMUSIE CONGENITALE)
NCT03094624
Pitch and Loudness Perception by Cochlear Implant Listeners: Psychophysics and Objective Measures
NCT01284790
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
NCT05176561
Paraverbal Components of Language and Cochlear Implant
NCT05950412
Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults
NCT02904187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cochlear implant users
In both arms a pitch training protocol and a visuo-spatial training protocol are applied.
Listening tests. Pitch training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
visuo-spatial training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
EEG/MEG/MRI recordings.
Listening tests. EEG/MEG/MRI recordings
Participants with Congenital Amusia
In both arms a pitch training protocol and a visuo-spatial training protocol are applied.
Listening tests. Pitch training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
visuo-spatial training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
EEG/MEG/MRI recordings.
Listening tests. EEG/MEG/MRI recordings
Control Participants
Listening tests. Pitch training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
visuo-spatial training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
EEG/MEG/MRI recordings.
Listening tests. EEG/MEG/MRI recordings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Listening tests. Pitch training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
visuo-spatial training protocol
The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.
EEG/MEG/MRI recordings.
Listening tests. EEG/MEG/MRI recordings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 90
* Absence of neurological and psychiatric disorders
* No major cognitive deficit, ability to understand and apply study instructions
* Motivation to participate efficiently in the study
* Written informed consent to participant in the study
* Affiliated to social security
* Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility
For underage participants:
* Subject aged 5 years and over
* Informed consent of parents or guardians for the participation of the child being studied
* No neurological or psychiatric history
* Without major cognitive impairment and ability to understand and apply setpoint.
* Subject affiliated to a social security scheme
* Motivation to participate effectively in the project
Exclusion Criteria
* Age below 18 or above 90
* Pregnant or breast-feeding woman
For underage participants:
\- Pregnant or nursing minors
5 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne CACLIN
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lyon Neuroscience Research Center
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02670-55
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL18_0632
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.